Surgical Oncology

• 

  Publication Venue For

  • Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review..  31:83-89. 2019
  • Disappearing liver metastases: A systematic review of the current evidence..  29:7-13. 2019
  • Histone deacetylase inhibitors in hepatocellular carcinoma: A therapeutic perspective..  27:611-618. 2018
  • Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence..  27:280-288. 2018
  • Program death-1 immune checkpoint and tumor microenvironment in malignant liver tumors..  26:423-430. 2017
  • Role of exosomes in treatment of hepatocellular carcinoma..  26:219-228. 2017
  • Surgery for palliation and treatment of advanced breast cancer..  16:249-257. 2007
  • Is there a role for sentinel lymph node biopsy in the management of sarcoma?.  12:201-206. 2003
  • Laparoscopic colectomy for cancer: an oncologic feasible option..  9:127-134. 2000
  • Modulation of specific active immunization against murine melanoma using recombinant cytokines..  5:221-229. 1996
  • Differential immunoreactivity of transforming growth factor alpha in benign, dysplastic and malignant prostatic tissues..  3:237-242. 1994
  • Retroviral gene transduction of circulating progenitor cells in patients with metastatic breast cancer..  2:1-6. 1993
  • The anatomy of missed breast cancers..  2:65-75. 1993
  • Laparoscopic feeding jejunostomy tube in oncology patients..  1:245-249. 1992
  • Differential immunoreactivity of her-2/neu oncoprotein in prostatic tissues..  1:151-155. 1992
  • Inhibition of the growth of human melanoma metastases in nude mice by melanoma-specific murine monoclonal antibody..  1:115-125. 1992
  • Adjuvant chemotherapy for colorectal hepatic metastases: role of route of administration and timing..  1:87-95. 1992
  • Effects of cyclosporine on human B-cell lymphoma development in vivo..  1:79-86. 1992